Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 4.305
-0.345 (-7.42%)
Mar 2, 2026, 5:12 PM CET
Mendus AB Market Cap
Mendus AB has a market cap or net worth of 264.11 million as of March 2, 2026. Its market cap has decreased by -30.08% in one year.
Market Cap
264.11M
Enterprise Value
218.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.31
Market Cap Chart
Since April 22, 2013, Mendus AB's market cap has increased from 117.09M to 264.11M, an increase of 125.56%. That is a compound annual growth rate of 6.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 285.27M | -16.81% |
| Dec 30, 2025 | 342.91M | -12.71% |
| Dec 30, 2024 | 392.86M | -12.97% |
| Dec 29, 2023 | 451.43M | -6.06% |
| Dec 30, 2022 | 480.56M | -43.76% |
| Dec 30, 2021 | 854.43M | -30.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 405.97M |
| Ascelia Pharma AB | 397.73M |
| Lipum AB | 307.58M |
| Elicera Therapeutics AB | 298.01M |
| Bio-Works Technologies AB | 283.36M |
| Xintela AB | 238.57M |
| AlzeCure Pharma AB | 216.61M |
| Initiator Pharma | 212.89M |